Biktarvy, formally known as bictegravir, represents a powerful single-tablet therapy for treating HIV infection. This formula unites three essential antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the the viral ability to copy within the body, considerably decreasing the viral burden. For many in